Postoperative management of malignant hyperthermia (MH) susceptible patients has changed substantially over the last 20 years, with many patients now managed as day cases. Our previous policy was to monitor known MH susceptible patients (and relatives of known MH susceptible individuals not yet investigated by muscle biopsy) for four hours in the Post Anaesthetic Care Unit. However, anaesthetic literature reports suggest that MH reactions usually commence within one hour of anaesthesia. For this reason we conducted a retrospective review of Post Anaesthetic Care Unit data in 254 MH susceptible/related patients treated between 1991 and late 2000. On the basis of this review we instituted a policy change and reduced our monitoring time to one hour in the Post Anaesthetic Care Unit with a further 1.5 h in a step-down unit if indicated. A prospective study in a further 68 MH susceptible/related patients showed that no MH reactions were missed due to the shorter monitoring period.
This study was carried out to determine the most appropriate duration of monitoring after nontriggering anaesthesia in patients who are susceptible to malignant hyperthermia (MH). Traditional management of MH susceptible patients has consisted of administering an anaesthetic free of MH triggering agents, and monitoring for 4-6 hours in a post anaesthetic care unit (PACU) 1, 2 . However, this prolonged monitoring increases staff requirements and use of resources. It is also unpleasant for patients, especially children.
Most studies of MH reactions developing in PACU indicate that almost all reactions occur within one hour of transfer if trigger agents have been used 3 . Similarly, when non-triggering agents have been used, the most convincing reactions have usually developed immediately postoperatively [4] [5] [6] . We therefore wanted to review our own experience, and then prospectively study a cohort of MH susceptible patients to determine if a shorter duration is safe.
METHODS
Our hospital serves a relatively large MH susceptible population as well as many patients who are potentially MH susceptible by familial connection (0.5% surgical patients). A database of MH cases has been maintained since 1991. On admission to hospital, MH susceptible/related patients are identified by history, reviewing past medical records, contacting relatives for further information, or running a query on the locally-held MH database. An audit form was completed for all patients who received an anaesthetic in this hospital.
Retrospective review
PACU data and hospital ward notes from 1991 until the end of 2000 were reviewed retrospectively. During this time, the PACU protocol observed a standard monitoring period of 4 hours for MH susceptible/related patients.
Prospective study
From November 2000 a change in protocol followed from the retrospective review and a prospective study was instituted with monitoring of patients for one hour only in PACU. Data was entered onto a dedicated database.
Following transfer to PACU, a set of observations was taken immediately and subsequently at 15 minute intervals, or more frequently if required-pulse rate, non-invasive blood pressure (NIBP), respiratory rate (RR), temperature. Tympanic membrane and nasal temperatures (particularly for general anaesthesia) were recorded using either an infrared emission detector thermometer (Braun-Thermoscan [BBraun] -which measures infrared heat generated by the tympanic membrane and surrounding auditory canal with an accuracy of ±0.53°C) 7 , or a thermistor sensor (Vital-Temp [Marquest Medical Products Inc, Englewood, CO, U.S.A.], a temperature probe measuring nasal core temperature, with an accuracy of ±0.2°C). In the early part of the study, axillary temperature was measured by digital thermometer. Continuous SpO 2 and end-tidal carbon dioxide (ETCO 2 ) measurements using a nasal sampling line were also carried out.
Arterial blood gases were measured only if tachycardia was sustained (120/min for 10 mins) or temperature was >38°C. If PACU measurements were stable after one hour (five measurements), patients were discharged to a step-down unit or the ward (if an overnight stay was required), where a set of three measurements were taken at half-hourly intervals (PR, BP, Temp, RR, SpO 2 ). Subsequently, ward patients were monitored hourly for four hours and then four-hourly. The day patients were discharged home from the step-down unit after three sets of observations, although for brief procedures (e.g. ventilation tubes-grommets, dental procedures) and in consultation with the procedural anaesthetist, patient discharge home was considered before the end of this period. This group tended to be restless younger children, and the risk of triggering an MH reaction was extremely low.
On discharge the patient and caregiver were given verbal and written advice to contact the hospital Duty Anaesthetist should anything untoward develop. Specifically, instructions were given to contact the hospital should the temperature be greater than 38°C, or if there was passage of dark urine. The patient, caregiver, or ward staff were contacted by telephone the following day by a registered PACU nurse, and specific enquiries were made about any potential problems and these were documented in the patient database. The majority of patients live within one and one half hours of the base hospital.
All patients who require testing for susceptibility to MH throughout New Zealand are tested at Massey University, Palmerston North (DNA) or Palmerston North Hospital (in vitro contracture test, IVCT). The European MH group protocol is used by the latter 8 . Contracture results are divided into three categories -abnormal contractures to both halothane and caffeine (MH susceptible-MHS), normal contractures (MH normal-MHN), or abnormally responding to one agent (MH equivocal-MHE). The latter group are considered to be MH susceptible until proved otherwise.
Individuals in families where a causative ryanodine receptor gene mutation (RYR1) has been identified, are regarded as susceptible once DNA confirmation is obtained. An individual with a negative DNA test must have an IVCT to confirm that he/she is not at risk for MH 9 .
Patients with previous MHS or MHE contracture study results, relatives of susceptible individuals who had not undergone IVCT (no biopsy done-NBD), relatives with a positive DNA test and an occasional patient awaiting investigation were included in the study. Age, gender, type of procedure, type and duration of anaesthesia, and intraoperative and postoperative monitoring were all recorded. Complications when noted were recorded.
All patients received a trigger-free anaesthetic technique using a dedicated anaesthesia machine not previously exposed to potent inhalational agents. General anaesthesia was usually maintained with an intravenous propofol infusion and supplemental opioids. Nondepolarizing neuromuscular blocking agents were used as appropriate for the surgical procedure. Alternatively, a regional technique was used with an amide local anaesthetic. The choice of anaesthesia was left to the anaesthetist but there were Departmental anaesthetic guidelines available.
RESULTS

Retrospective review
A total of 254 procedures (216 patients) were included in the retrospective review. One hundred and one procedures were on MHS patients, 23 on MHE patients and 130 NBD patients ( Figure 1 ). The majority in this group were younger patients, less than 16 years of age. Ages in all groups ranged from one to 74 years (mean 23 y), and anaesthesia time from 15 minutes to 4 hours 20 min (mean 53 min). One hundred and ninety-six patients (77%) received general anaesthesia and 58 (23%) regional. General surgical procedures accounted for 66 cases (26%), muscle biopsies 58 (23%) and the remainder a mixture of orthopaedic, obstetric, gynaecological and other procedures ( Figure 2 ).
Intraoperatively, no patient developed an MH reaction. Table 1 illustrates PACU data from this group. The range of heart rates were higher in children (65-152 bpm) than adults (55-134 bpm). Similarly, respiratory rates were higher in children (12- >38°C. These all received general anaesthesia. In four patients the pyrexia developed after discharge from PACU. In one of the four a chest infection was considered the cause of the pyrexia. The cause was not determined in the other three, but temperatures settled with paracetamol. Two of the fifteen patients recorded temperatures >40°C in PACU. One was explained by intra-abdominal sepsis, and ABGs were normal in the other. There was no evidence of hypermetabolism (increased ETCO 2 , tachycardia, reduced SpO 2 ), and these were not considered MH reactions.
There was an infective cause in another two patients.
In the remaining seven patients a cause was not determined. Twenty patients (8%) had an SpO 2 <95%. These were readily corrected with supplemental oxygen. Three patients had minor arrhythmias (ventricular ectopics (2), or bigeminy) which settled. A high respiratory rate was quite frequently encountered in younger children with tachycardia but without pyrexia.
Arterial blood gases were measured in 15 patients and apart from a mild acidosis in two, there were no other significant abnormalities. Electrolytes and creatine kinase (CK) were measured in 13 patients with no abnormality. Overall in these 254 procedures, three ranked 4 on the Malignant Hyperthermia Clinical Grading Scale (MHCGS) 10 . However no patient was considered to have developed an MH reaction.
Complications were infrequent and consisted of nausea and vomiting (7 patients), increased sedation (2 patients), laryngospasm (1 patient) and bronchospasm (1 patient).
Prospective study
Sixty-eight procedures (65 patients) were included in the prospective study ( Figure 3 ). Ages ranged from one to 68 years (mean 26 y). Figure 3 also shows the MH status. There were 27 procedures in MHS patients, 5 on MHE patients and 36 on NBD patients. Anaesthetic technique is also shown in Figure 3 . Figure 4 illustrates the surgical procedures performed. General surgery comprised the largest group, 18 patients (19%). Duration of anaesthesia ranged from 15 min to 2 hours 45 min (mean 49 min). Table 2 presents PACU data from this group. Again, the range of heart and respiratory rates were higher in children than adults, similar to the retrospective group.
Five patients recorded ETCO 2 >50 mm but other parameters such as respiratory rate and pulse rate were normal. Five patients recorded SpO 2 <95%, all had received general anaesthesia and all improved with oxygen supplementation. No patient developed significant pyrexia. Normal CK measurements were noted in five. There was no indication for arterial blood gas estimation. Again, no patient was considered to have developed an MH reaction and therefore no patient was treated with dantrolene.
Twenty-one per cent stayed longer than one hour in PACU, mainly due to problems with patient transfer, but discharge was delayed in others due to excessive sedation (1), confusion (1) and hypothermia (1). These were the only significant complications recorded. Tachycardia (4 patients), minor pyrexia (4 patients) and SpO 2 <95% (1 patient) were the only problems noted in the step-down unit. 
POSTOPERATIVE MANAGEMENT OF MH SUSCEPTIBLE PATIENTS
Anaesthesia and Intensive Care, Vol. 32, No. 4, August 2004 Nursing staff followed up patients from 65 procedures (97%) after discharge. The remaining three were not contacted because of staff unavailability. No complications were noted from patient, caregiver or ward staff. Seventy-two per cent of procedures were managed as day stay.
DISCUSSION
This is a limited study, and greater numbers will be required to confirm that one hour of close observation is sufficient. The retrospective review covered 254 procedures, 101 of which were carried out in confirmed MHS patients. The observations in PACU were well documented in the notes, and the most abnormal observations recorded in the database. However, the fact that no MH episode was triggered in this series of patients does not mean that it could never occur. One case of late presentation has been well documented in our own hospital prior to this review 6 . In this patient signs of MH occurred before the end of his four-hour procedure, and were prominent within 30 minutes of transfer, despite a nontriggering general anaesthetic. Statistically there is a 0-1.2% possibility using the principles of inferential statistics that apply to zero numerators that a reaction could occur, given sufficient numbers, if all 254 procedures reviewed were indeed on people at risk of MH. If those not yet tested (of whom 50% may be expected to be MHS), and MHE patients are excluded, that leaves 101 procedures on definite MHS individuals. This increases to 3.0% the possibility of reaction occurring within 95% confidence limits again using the above principles. The risk of stress itself triggering MH has been discussed at length in previous studies, and was considered to have contributed to the reaction in the patient discussed above 6 . However, if only general anaesthesia is considered as the risk factor, data from the retrospective review carried out under non-triggering general anaesthesia on MHS individuals (80 patients) suggests a slightly increased possibility of 3.8% 11 . Patients with regional anaesthesia comprised 21-23% of the study groups. There are no conclusive reports of MH reactions developing in patients with amide or ester use and these agents are regarded as safe in regional and local anaesthetic procedures. Several reactions have been reported associated with regional anaesthesia but they score low on the MHCGS 12, 13 . Early research found that an epidural had a protective effect 15 and subsequent publications have indicated no problems 16 . None of the study patients who had regional anaesthesia developed signs of MH. PACU patients who have had regional anaesthesia are now monitored in the same way as other patients.
The four-hour observation period has been observed internationally for some years. It is difficult to trace its origins, but it was referred to by Britt in 1977 although it may have been established earlier 17 . Britt advocated a period of 24 hours observation and others have suggested at least an overnight stay 18, 19 . Yentis questioned this management and found that of 285 MH susceptible/suspected children (406 procedures) undergoing standard surgical procedures, 57% were admitted overnight solely for MH observation, experienced no significant complications and could have been managed as day cases 3 .
MH susceptible patients are monitored in our standard recovery area, and 72% are day cases. Peak halothane levels in this area have been measured at 1.5 ppm 20 . There are 14 fresh gas exchanges per hour in PACU in this institution. The minimum concentration of inhalational agent that will trigger an MH reaction is unknown. There is no known episode of an MH susceptible individual developing a reaction while working in an operating theatre environment 21 . Macani et al found that prolonged exposure of susceptible swine to 5 ppm halothane failed to trigger a reaction 22 . Other inhalational agents are less potent triggers. Agent levels in a well-ventilated PACU should be less than 5 ppm.
MH reactions can become apparent in PACU and, where trigger agents have been involved, all events with one exception 23 have developed within one hour of transfer to PACU [24] [25] [26] [27] . Reported reactions following trigger-free anaesthesia are few and in general, mild [4] [5] [6] [28] [29] [30] [31] [32] [33] . Time of onset is more variable and no fatalities have been reported from these reactions. The majority have developed in PACU, achieve an MHCGS <4 (unlikely to be MH reaction), and several at least have been questionable true MH reactions 14 . However one reaction demonstrated increased CO 2 production 5 , another prolonged pyrexia, raised creatine kinase, increased ETCO 2 and moderate acidosis 6 , which suggests that some of these reactions cannot be completely discounted.
The denominator for these observations is impossible to determine, but it would seem to be very large. Our review, even if the largest risk is taken, would suggest that the incidence of an MH reaction occurring within four hours of surgery is less that 3.8%. Our policy, on which this audit is based, is for PACU observation for one hour, then a further 90 minutes of observation before discharge (a total of 2.5 hours). Some young children were discharged sooner, and these were usually after minor procedures requiring one or two doses of propofol and oxygen administration (e.g. for insertion of ventilation tubes). Monitoring of young children can be difficult, especially ETCO 2 measurement, and therefore may be inaccurate. However a hypermetabolic event would be clearly detected if increased respiratory rate, tachycardia and increasing temperature were all present.
The retrospective review demonstrated that high temperatures in an MH susceptible patient do not necessarily indicate an MH reaction. Postoperative isolated pyrexia has been shown to be a poor predictor of an MH reaction, and postoperative pyrexia is not uncommon following surgical procedures, particularly in children 34 .
The prospective audit was of a total of 68 procedures, of which 27 were carried out on definite MHS individuals. These numbers are still very small. However, no patient developed signs suggestive of MH after discharge. There were no signs of hypermetabolism during the one-hour period of close observation. The audit is continuing. If the 27 procedures carried out on MHS individuals only are considered (of which 14 were muscle biopsy for IVCT) then it can be stated with 95% confidence that the risk of a reaction occurring is 0-11%. This may be considered too high. If the 20 carried out under general anaesthesia are considered the only valid observations, then the range increases to 0-15%.
Obviously, greater numbers are required to confirm that this change in policy is safe. Ideally 300 confirmed MHS individuals having procedures carried out under non-triggering general anaesthesia would be required to have 95% confidence limits of less than 1% risk. This will take several years. It is worth reporting these interim results, so that others may consider changing their hospital policy. The policy must provide back-up for the caregivers, with information about what signs to look for (especially high temperature or dark, "cola-coloured", urine), and who to telephone if there are problems or concerns 35 . This hospital will continue with one-hour close monitoring in PACU, because we believe the risk of developing an MH reaction after one hour is low, based on previous studies, and our own retrospective review.
